Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,060,877
-$322,288 QoQ
Shares Held
2,116
-24.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#1,413
of 2,606 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Prostatis Group LLC holds $1,275,157 across 2 Diagnostics & Research names. TMO ranks #1 (83.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
2,116 | $1,060,877 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
1,109 | $214,280 |
All Filings in TMO
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,060,877 | 2,116 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,383,165 | 2,814 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,551,767 | 2,678 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,159,682 | 2,391 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $969,454 | 2,391 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,206,182 | 2,424 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $1,297,973 | 2,495 | Shares | Sole | 2025-03-21 | |
| 2024-09-30 | $1,526,012 | 2,467 | Shares | Sole | 2025-03-21 | |
| 2024-06-30 | $1,409,597 | 2,549 | Shares | Sole | 2025-03-21 | |
| 2024-03-31 | $1,529,163 | 2,631 | Shares | Sole | 2025-03-21 | |
| 2023-12-31 | $1,444,810 | 2,722 | Shares | Sole | 2025-03-21 | |
| 2023-09-30 | $1,431,954 | 2,829 | Shares | Sole | 2025-03-21 | |
| 2023-06-30 | $1,473,367 | 1,452,094 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,627,668 | 2,824 | Shares | Sole | 2023-05-22 | |
| No filing history on record for this holder in this stock. | ||||||